Introduction The emergence of cuffless blood pressure (BP) monitors has opened new frontiers in cardiovascular and metabolic health monitoring. These wearable and often continuous monitoring systems promise to transform hypertension management and preventive care by offering convenience, real-time data, and better patient adherence. However, without rigorous clinical validation, these innovations cannot achieve regulatory clearance—or clinical trust. Unlike traditional cuff-b